- Home
- EVOK vs UBXG Comparison
EVOK vs UBXG Comparison
Compare EVOK & UBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- UBXG
- Stock Information
- Founded
- EVOK 2007
- UBXG 2018
- Country
- EVOK United States
- UBXG China
- Employees
- EVOK N/A
- UBXG N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- UBXG
- Sector
- EVOK Health Care
- UBXG
- Exchange
- EVOK Nasdaq
- UBXG Nasdaq
- Market Cap
- EVOK 4.2M
- UBXG N/A
- IPO Year
- EVOK 2013
- UBXG 2024
- Fundamental
- Price
- EVOK $6.09
- UBXG $3.19
- Analyst Decision
- EVOK
- UBXG
- Analyst Count
- EVOK 0
- UBXG 0
- Target Price
- EVOK N/A
- UBXG N/A
- AVG Volume (30 Days)
- EVOK 7.2M
- UBXG 7.1K
- Earning Date
- EVOK 08-12-2025
- UBXG 01-01-0001
- Dividend Yield
- EVOK N/A
- UBXG N/A
- EPS Growth
- EVOK N/A
- UBXG N/A
- EPS
- EVOK N/A
- UBXG N/A
- Revenue
- EVOK $11,594,083.00
- UBXG $39,603,353.00
- Revenue This Year
- EVOK $57.82
- UBXG N/A
- Revenue Next Year
- EVOK $59.12
- UBXG N/A
- P/E Ratio
- EVOK N/A
- UBXG N/A
- Revenue Growth
- EVOK 89.89
- UBXG N/A
- 52 Week Low
- EVOK $1.94
- UBXG $2.36
- 52 Week High
- EVOK $12.32
- UBXG $567.04
- Technical
- Relative Strength Index (RSI)
- EVOK 74.84
- UBXG N/A
- Support Level
- EVOK $2.52
- UBXG N/A
- Resistance Level
- EVOK $9.88
- UBXG N/A
- Average True Range (ATR)
- EVOK 0.49
- UBXG 0.00
- MACD
- EVOK 0.39
- UBXG 0.00
- Stochastic Oscillator
- EVOK 49.19
- UBXG 0.00
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.